BB Biotech AG
Investment company focused on public biotechnology firms developing novel drugs.
BION | SW
Overview
Corporate Details
- ISIN(s):
- CH0027659793 (+1 more)
- LEI:
- 391200MBZQNPFHIVKO34
- Country:
- Switzerland
- Address:
- Schwertstrasse 6, 8200 Schaffhausen
Description
BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-07 09:54 |
Edison issues review on BB Biotech (BION)
|
English | 10.2 KB | ||
| 2023-02-17 07:00 |
BB Biotech AG publishes its 2022 annual report
|
English | 8.6 KB | ||
| 2023-02-17 01:00 |
EQS-Adhoc: BB Biotech AG pubblica il rapporto annuale 2022
|
Italian | 7.2 KB | ||
| 2023-02-17 01:00 |
EQS-Adhoc: BB Biotech AG publishes its 2022 annual report
|
English | 6.8 KB | ||
| 2023-02-17 01:00 |
EQS-Adhoc: BB Biotech AG veröffentlicht Geschäftsbericht 2022
|
German | 7.3 KB | ||
| 2023-02-17 00:00 |
Annual financial report 2022
|
English | 27.5 MB | ||
| 2023-02-17 00:00 |
Jahresfinanzbericht 2022
|
German | 28.6 MB | ||
| 2023-01-20 07:00 |
BB Biotech AG closes the 2022 fiscal year with a loss
|
English | 6.2 KB | ||
| 2023-01-20 01:00 |
EQS-News: BB BIOTECH AG: L’andamento dei mercati azionari biotecnologici riflet…
|
Italian | 27.2 KB | ||
| 2023-01-20 01:00 |
EQS-News: BB BIOTECH AG: Divergent biotech equity markets mirror value over gro…
|
English | 23.8 KB | ||
| 2023-01-20 01:00 |
EQS-News: BB BIOTECH AG: Uneinheitliche Entwicklung der Biotechaktien spiegeln …
|
German | 26.1 KB | ||
| 2023-01-20 01:00 |
EQS-Adhoc: BB Biotech AG registra una perdita al termine dell’esercizio 2022
|
Italian | 4.8 KB | ||
| 2023-01-20 01:00 |
EQS-Adhoc: BB Biotech AG closes the 2022 fiscal year with a loss
|
English | 4.6 KB | ||
| 2023-01-20 01:00 |
EQS-Adhoc: BB Biotech AG mit Verlust im Geschäftsjahr 2022
|
German | 4.8 KB | ||
| 2022-12-08 17:00 |
BB BIOTECH AG: Molecular strike force for the immune system
|
English | 15.3 KB |
Automate Your Workflow. Get a real-time feed of all BB Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BB Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BB Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-05 | N/A | Non-Executive member | Buy | None | 40,893.80 CHF |
| 2024-09-16 | N/A | Non-Executive member | Buy | None | 47,103.20 CHF |
| 2024-07-29 | N/A | Non-Executive member | Buy | None | 54,913.50 CHF |
| 2024-04-30 | N/A | Non-Executive member | Buy | None | 41,450.00 CHF |
| 2024-03-25 | N/A | Non-Executive member | Buy | None | 55,167.50 CHF |
| 2024-03-22 | N/A | Non-Executive member | Buy | None | 105,927.16 CHF |
Peer Companies
